rs777311066

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_005529.7(HSPG2):​c.*103G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000379 in 1,142,550 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00042 ( 2 hom. )

Consequence

HSPG2
NM_005529.7 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: -0.578

Publications

0 publications found
Variant links:
Genes affected
HSPG2 (HGNC:5273): (heparan sulfate proteoglycan 2) This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
LDLRAD2 (HGNC:32071): (low density lipoprotein receptor class A domain containing 2) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.00042 (416/990340) while in subpopulation NFE AF = 0.000522 (410/785658). AF 95% confidence interval is 0.00048. There are 2 homozygotes in GnomAdExome4. There are 186 alleles in the male GnomAdExome4 subpopulation. Median coverage is 13. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005529.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HSPG2
NM_005529.7
MANE Select
c.*103G>A
3_prime_UTR
Exon 97 of 97NP_005520.4
LDLRAD2
NM_001013693.3
MANE Select
c.*998C>T
3_prime_UTR
Exon 5 of 5NP_001013715.2Q5SZI1
HSPG2
NM_001291860.2
c.*103G>A
3_prime_UTR
Exon 97 of 97NP_001278789.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HSPG2
ENST00000374695.8
TSL:1 MANE Select
c.*103G>A
3_prime_UTR
Exon 97 of 97ENSP00000363827.3P98160
LDLRAD2
ENST00000344642.7
TSL:2 MANE Select
c.*998C>T
3_prime_UTR
Exon 5 of 5ENSP00000340988.2Q5SZI1
LDLRAD2
ENST00000543870.1
TSL:1
c.*219-697C>T
intron
N/AENSP00000444097.1Q5SZI1

Frequencies

GnomAD3 genomes
AF:
0.000112
AC:
17
AN:
152210
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.000420
AC:
416
AN:
990340
Hom.:
2
Cov.:
13
AF XY:
0.000384
AC XY:
186
AN XY:
484446
show subpopulations
African (AFR)
AF:
0.0000449
AC:
1
AN:
22260
American (AMR)
AF:
0.00
AC:
0
AN:
17396
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31314
South Asian (SAS)
AF:
0.00
AC:
0
AN:
43772
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
28044
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2940
European-Non Finnish (NFE)
AF:
0.000522
AC:
410
AN:
785658
Other (OTH)
AF:
0.000117
AC:
5
AN:
42820
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
18
36
55
73
91
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000112
AC:
17
AN:
152210
Hom.:
0
Cov.:
33
AF XY:
0.0000807
AC XY:
6
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41456
American (AMR)
AF:
0.00
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68040
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000693
Hom.:
0
Bravo
AF:
0.000144

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Lethal Kniest-like syndrome (1)
-
1
-
not provided (1)
-
1
-
Schwartz-Jampel syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.50
CADD
Benign
9.7
DANN
Benign
0.86
PhyloP100
-0.58
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
2.3

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs777311066; hg19: chr1-22149706; API